Literature DB >> 4146876

Sectral in the management of angina pectoris.

B S Lewis, A Bakst, D J Kitchiner, M S Gotsman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4146876

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  8 in total

1.  Electrophysiological effects of acebutolol.

Authors:  J W Mason; R A Winkle; P J Meffin; D C Harrison
Journal:  Br Heart J       Date:  1978-01

2.  Haemodynamic effects of acebutolol.

Authors:  J W Mason; M J Specter; N B Ingels; G T Daughters; A C Ferris; E L Alderman
Journal:  Br Heart J       Date:  1978-01

3.  Differential antianginal responsiveness to acebutolol.

Authors:  P Biron; G Tremblay
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

4.  Preliminary observations on the elimination of acebutolol in severe chronic renal failure.

Authors:  C M Kaye; J F Dufton
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

5.  Properties of acebutolol in twenty patients with cardiac arrhythmias.

Authors:  P Biron; A Proulx; L Lapointe; R Nadeau; G Tremblay
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

6.  Acebutolol metabolite plasma concentration during chronic oral therapy.

Authors:  R A Winkle; P J Meffin; W B Ricks; D C Harrison
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 7.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

8.  Acebutolol in hypertension--double-blind trial against placebo.

Authors:  M A Martin; C A Phillips; A J Smith
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.